The 20S proteasome ChT-L activity, NF-κB1 and NF-κB2 concentration were analyzed in 31 brain tumor samples and 10 non-tumoral individuals (in 2 brain tumor cases we did not have preserved plasma samples). Here, NFKB1 is linked to brain neoplasm.